In the beginning, the idea of the cathepsin K expression in translocation renal cell carcinoma was postulated based on the consistent ability of MiTF to modulate the cathepsin K gene promoter in osteoclasts. The gene discussed is CTSK; the disease is MIT family translocation renal cell carcinoma.